Cash flow Cigna

Equities

CI

US1255231003

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 12:10:31 21/04/2026 am IST			5-day change	1st Jan Change
278.71 ^USD	+0.03%		+1.43%	+1.39%

04:39pm	Jefferies Adjusts Price Target on Cigna Group to $330 From $333, Maintains Buy Rating	MT
15/04	Baird Adjusts Cigna Price Target to $306 From $315, Maintains Outperform Rating	MT

fc.Acnpqnwd9AP_bA9KdhTBO2UnooE77bxWf3x7AX7Kbv4.Mouk6y5rk3OLKWIaQ2WtAiBT97J8jNMXLhYMXhWiGLJeoYv-LXnDLqghVg

Published financial data: CIGNA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	17TCr	18TCr	19TCr	25TCr	27TCr
Gain (Loss) on Sale of Investment, Total (Rev)	-	-	-	-	-
Interest And Invest. Income (Rev)	154.9Cr	115.5Cr	116.6Cr	97Cr	104.6Cr
Total Revenues	17TCr	18TCr	20TCr	25TCr	27TCr
Cost of Goods Sold, Total	15TCr	16TCr	17TCr	22TCr	25TCr
Gross Profit	2.3TCr	2.35TCr	2.52TCr	2.6TCr	2.56TCr
Selling General & Admin Expenses, Total	1.28TCr	1.31TCr	1.44TCr	1.46TCr	1.36TCr
Stock-Based Compensation (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	199.8Cr	187.6Cr	181.9Cr	170.3Cr	174.3Cr
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	1.48TCr	1.5TCr	1.62TCr	1.63TCr	1.53TCr
Operating Income	815.6Cr	847.8Cr	898.8Cr	969.2Cr	1.03TCr
Interest Expense, Total	-111.9Cr	-116.3Cr	-140Cr	-150Cr	-140Cr
Net Interest Expenses	-111.9Cr	-116.3Cr	-140Cr	-150Cr	-140Cr
Other Non Operating Income (Expenses)	-	-	-	6.5Cr	-80L
EBT, Excl. Unusual Items	703.7Cr	731.5Cr	758.8Cr	825.7Cr	885.1Cr
Restructuring Charges	-17Cr	-2.2Cr	-25Cr	-	-75Cr
Merger & Related Restructuring Charges	-17Cr	-14Cr	-4.5Cr	-28Cr	-33Cr
Gain (Loss) On Sale Of Investments	20Cr	-50Cr	-7.8Cr	-273.7Cr	-2.4Cr
Gain (Loss) On Sale Of Assets	-	166.2Cr	-149.9Cr	2.4Cr	1.3Cr
Legal Settlements	2.7Cr	2.8Cr	-20Cr	-	1.7Cr
Other Unusual Items	-14Cr	-	-	-	-
EBT, Incl. Unusual Items	678.2Cr	835.3Cr	551.3Cr	526.9Cr	778.1Cr
Income Tax Expense	136.7Cr	160.7Cr	14Cr	149.1Cr	149.3Cr
Earnings From Continuing Operations	541.5Cr	674.6Cr	537.2Cr	377.8Cr	628.8Cr
Net Income to Company	541.5Cr	674.6Cr	537.2Cr	377.8Cr	628.8Cr
Minority Interest	-5Cr	-7.8Cr	-21Cr	-34Cr	-33Cr
Net Income - (IS)	536.5Cr	666.8Cr	516.4Cr	343.4Cr	595.7Cr
Net Income to Common Incl Extra Items	536.5Cr	666.8Cr	516.4Cr	343.4Cr	595.7Cr
Net Income to Common Excl. Extra Items	536.5Cr	666.8Cr	516.4Cr	343.4Cr	595.7Cr
Per Share Items
Net EPS - Basic	15.87	21.54	17.57	12.25	22.33
Basic EPS - Continuing Operations	15.87	21.54	17.57	12.25	22.33
Basic Weighted Average Shares Outstanding	34Cr	31Cr	29Cr	28Cr	27Cr
Net EPS - Diluted	15.73	21.3	17.39	12.12	22.18
Diluted EPS - Continuing Operations	15.73	21.3	17.39	12.12	22.18
Diluted Weighted Average Shares Outstanding	34Cr	31Cr	30Cr	28Cr	27Cr
Normalized Basic EPS	12.87	14.52	15.43	17.18	19.5
Normalized Diluted EPS	12.75	14.35	15.27	17.01	19.37
Dividend Per Share	4	4.48	4.92	5.6	6.04
Payout Ratio	25	20.76	28.08	45.63	27.04
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	995.7Cr	1.03TCr	1.08TCr	1.14TCr	1.2TCr
EBITA	970.4Cr	1.01TCr	1.05TCr	1.12TCr	1.18TCr
EBIT	815.6Cr	847.8Cr	898.8Cr	969.2Cr	1.03TCr
EBITDAR	1.02TCr	1.05TCr	1.1TCr	-	-
Total Revenues (As Reported)	17TCr	18TCr	20TCr	25TCr	27TCr
Effective Tax Rate - (Ratio)	20.16	19.24	2.56	28.3	19.19
Current Domestic Taxes	138Cr	186.8Cr	163.9Cr	133.8Cr	98Cr
Current Foreign Taxes	21Cr	22Cr	16Cr	25Cr	19Cr
Total Current Taxes	158.7Cr	208.7Cr	180Cr	158.6Cr	116.7Cr
Deferred Domestic Taxes	-29Cr	-45Cr	-61Cr	-16Cr	-12Cr
Deferred Foreign Taxes	6.9Cr	-2.8Cr	-104.6Cr	6.4Cr	45Cr
Total Deferred Taxes	-22Cr	-48Cr	-165.9Cr	-9.5Cr	33Cr
Normalized Net Income	434.81Cr	449.39Cr	453.45Cr	481.66Cr	520.09Cr
Interest on Long-Term Debt	20L	20L	40L	-	-
Non-Cash Pension Expense	-5.5Cr	-4.3Cr	5.2Cr	-1.3Cr	20L
Supplemental Operating Expense Items
Net Rental Expense, Total	21Cr	16Cr	15Cr	-	-
Imputed Operating Lease Interest Expense	5.52Cr	4.66Cr	5.45Cr	-	-
Imputed Operating Lease Depreciation	15Cr	12Cr	9.85Cr	-	-
Stock-Based Comp., SG&A Exp. (Total)	18Cr	17Cr	22Cr	24Cr	20Cr
Stock-Based Comp., Other (Total)	8.5Cr	9.7Cr	6.6Cr	7Cr	8.8Cr
Total Stock-Based Compensation	27Cr	26Cr	29Cr	31Cr	29Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	508.1Cr	592.4Cr	782.2Cr	755Cr	767.6Cr
Short Term Investments	92Cr	90Cr	92Cr	66Cr	105.6Cr
Total Cash And Short Term Investments	600.1Cr	682.9Cr	874.7Cr	821.5Cr	873.2Cr
Accounts Receivable, Total	1.46TCr	1.7TCr	1.77TCr	2.41TCr	2.85TCr
Other Receivables	58Cr	42Cr	18Cr	32Cr	36Cr
Total Receivables	1.52TCr	1.74TCr	1.79TCr	2.44TCr	2.89TCr
Inventory	372.2Cr	477.7Cr	564.5Cr	669.2Cr	733.8Cr
Other Current Assets, Total	1.12TCr	112.2Cr	505.4Cr	957.7Cr	285.6Cr
Total Current Assets	3.61TCr	3.01TCr	3.74TCr	4.89TCr	4.78TCr
Gross Property Plant And Equipment	331.7Cr	263.1Cr	265.2Cr	211.5Cr	207.5Cr
Accumulated Depreciation	-165.3Cr	-133Cr	-140.5Cr	-128.7Cr	-119.8Cr
Net Property Plant And Equipment	166.4Cr	130.1Cr	124.7Cr	83Cr	88Cr
Long-term Investments	1.84TCr	1.71TCr	1.81TCr	1.51TCr	1.85TCr
Goodwill	4.58TCr	4.58TCr	4.43TCr	4.44TCr	4.49TCr
Other Intangibles, Total	3.66TCr	3.53TCr	3.38TCr	3.22TCr	3.13TCr
Deferred Tax Assets Long-Term	-	-	228.9Cr	95Cr	46Cr
Deferred Charges Long-Term	68Cr	-	-	-	-
Other Long-Term Assets, Total	1.56TCr	1.42TCr	1.57TCr	1.35TCr	1.4TCr
Total Assets	15TCr	14TCr	15TCr	16TCr	16TCr
Liabilities
Accounts Payable, Total	2.2TCr	2.48TCr	2.84TCr	3.78TCr	4.1TCr
Accrued Expenses, Total	716.3Cr	789.2Cr	964.8Cr	648.7Cr	670.8Cr
Short-term Borrowings	202.7Cr	-	123.7Cr	88Cr	-
Current Portion of Long-Term Debt	50Cr	296Cr	149.6Cr	211.2Cr	55Cr
Current Portion of Leases	18Cr	15Cr	15Cr	4.3Cr	4.3Cr
Unearned Revenue Current, Total	-	58Cr	85Cr	75Cr	82Cr
Other Current Liabilities	1.17TCr	480.9Cr	697.4Cr	994.5Cr	722.8Cr
Total Current Liabilities	4.36TCr	4.12TCr	4.87TCr	5.8TCr	5.63TCr
Long-Term Debt	3.11TCr	2.8TCr	2.81TCr	2.89TCr	3.08TCr
Long-Term Leases	46Cr	41Cr	41Cr	4.1Cr	6.8Cr
Unearned Revenue Non Current	-	2.2Cr	2.2Cr	3.1Cr	4Cr
Pension & Other Post Retirement Benefits	36Cr	-	-	-	-
Deferred Tax Liability Non Current	834.6Cr	775.1Cr	717.3Cr	697.5Cr	714.5Cr
Other Non Current Liabilities	2.39TCr	2.15TCr	2.2TCr	2.07TCr	2.16TCr
Total Liabilities	11TCr	9.9TCr	11TCr	11TCr	12TCr
Common Stock, Total	40L	40L	40L	40L	40L
Additional Paid In Capital	2.96TCr	3.02TCr	3.07TCr	3.13TCr	3.18TCr
Retained Earnings	3.26TCr	3.79TCr	4.17TCr	4.35TCr	4.79TCr
Treasury Stock	-1.42TCr	-2.18TCr	-2.42TCr	-3.14TCr	-3.51TCr
Comprehensive Income and Other	-88Cr	-139.5Cr	-186.4Cr	-234.1Cr	-280.6Cr
Total Common Equity	4.71TCr	4.49TCr	4.62TCr	4.1TCr	4.17TCr
Minority Interest	7.2Cr	7.9Cr	13Cr	21Cr	16Cr
Total Equity	4.72TCr	4.5TCr	4.64TCr	4.12TCr	4.19TCr
Total Liabilities And Equity	15TCr	14TCr	15TCr	16TCr	16TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32Cr	30Cr	29Cr	27Cr	26Cr
ECS Total Common Shares Outstanding	32Cr	30Cr	29Cr	27Cr	26Cr
Book Value / Share	145.88	150.24	158.03	149.87	158.33
Tangible Book Value	-3.53TCr	-3.63TCr	-3.18TCr	-3.56TCr	-3.45TCr
Tangible Book Value Per Share	-109.33	-121.47	-108.7	-129.95	-131.12
Total Debt	3.43TCr	3.16TCr	3.14TCr	3.2TCr	3.15TCr
Net Debt	2.83TCr	2.47TCr	2.26TCr	2.38TCr	2.27TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	38Cr	-24Cr	-20Cr	-21Cr	-22Cr
Debt Equivalent Oper. Leases	167.2Cr	132Cr	122.4Cr	-	-
Minority Interest, Total (Incl. Fin. Div)	7.2Cr	7.9Cr	13Cr	21Cr	16Cr
Equity Method Investments, Total	-	90Cr	20Cr	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Full Time Employees	73.7T	69.16T	70.32T	71.3T	65.67T
Part Time Employees	-	2.14T	2.18T	2.2T	2.03T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	124.7Cr	34Cr	-	8.4Cr	20Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	536.5Cr	666.8Cr	516.4Cr	343.4Cr	595.7Cr
Depreciation & Amortization - CF	25Cr	25Cr	26Cr	25Cr	24Cr
Amortization of Goodwill and Intangible Assets - (CF)	154.8Cr	160.6Cr	155.2Cr	150.6Cr	154.9Cr
Depreciation & Amortization, Total	180.1Cr	185.7Cr	181.2Cr	175.4Cr	178.8Cr
Amortization of Deferred Charges, Total - (CF)	112.2Cr	108Cr	122.3Cr	102.1Cr	99Cr
(Gain) Loss From Sale Of Asset	-	-166.2Cr	149.9Cr	-2.4Cr	-1.3Cr
(Gain) Loss on Sale of Investments - (CF)	-20Cr	50Cr	7.8Cr	273.7Cr	2.4Cr
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-2.9Cr	-40Cr	-145.1Cr	25Cr	66Cr
Change In Accounts Receivable	-284.3Cr	-223.7Cr	-166.3Cr	-736.9Cr	-463Cr
Change In Inventories	-56Cr	-105.5Cr	-87Cr	-103.2Cr	-65Cr
Change In Accounts Payable	188.4Cr	333.4Cr	551.1Cr	989.5Cr	466.5Cr
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	64Cr	58Cr	51Cr	-30Cr	81Cr
Cash from Operations	719.1Cr	865.6Cr	1.18TCr	1.04TCr	960.1Cr
Capital Expenditure	-115.4Cr	-129.5Cr	-157.3Cr	-140.6Cr	-121.2Cr
Cash Acquisitions	-183.3Cr	-	-45Cr	-13Cr	-60Cr
Divestitures	-6.1Cr	483.5Cr	1.3Cr	52Cr	298.4Cr
Investment in Marketable and Equity Securities, Total	-51Cr	-21Cr	-290.3Cr	-25Cr	-455.2Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-15Cr	-6.3Cr	6.8Cr	13Cr	11Cr
Other Investing Activities, Total	9.7Cr	-17Cr	-33Cr	-97Cr	-113.6Cr
Cash from Investing	-361.1Cr	309.8Cr	-517.4Cr	-210.2Cr	-440.7Cr
Short Term Debt Issued, Total	98Cr	-	119.8Cr	-	-
Long-Term Debt Issued, Total	426Cr	-	149.1Cr	446.2Cr	645.7Cr
Total Debt Issued	523.5Cr	-	268.9Cr	446.2Cr	645.7Cr
Short Term Debt Repaid, Total	-	-205.9Cr	-	-40Cr	-93Cr
Long-Term Debt Repaid, Total	-457.8Cr	-50Cr	-296.7Cr	-300Cr	-619.7Cr
Total Debt Repaid	-457.8Cr	-255.9Cr	-296.7Cr	-340.2Cr	-712.4Cr
Issuance of Common Stock	33Cr	39Cr	19Cr	30Cr	20Cr
Repurchase of Common Stock	-774.2Cr	-760.7Cr	-228.4Cr	-703.4Cr	-362.1Cr
Common Dividends Paid	-134.1Cr	-138.4Cr	-145Cr	-156.7Cr	-161.1Cr
Common & Preferred Stock Dividends Paid	-134.1Cr	-138.4Cr	-145Cr	-156.7Cr	-161.1Cr
Other Financing Activities, Total	-11Cr	-7.9Cr	-47Cr	-41Cr	-72Cr
Cash from Financing	-821.2Cr	-1.12TCr	-429.4Cr	-764.7Cr	-642.1Cr
Foreign Exchange Rate Adjustments	-6.5Cr	-8.6Cr	1.6Cr	-2Cr	3.2Cr
Miscellaneous Cash Flow Adjustments	-42Cr	-	-47Cr	-133.9Cr	-
Net Change in Cash	-512.2Cr	43Cr	189.4Cr	-74Cr	-119.5Cr
Supplemental Items
Cash Interest Paid	125.3Cr	122.9Cr	133Cr	134.2Cr	135Cr
Cash Income Tax Paid (Refund)	224Cr	185Cr	147.1Cr	90Cr	40Cr
Levered Free Cash Flow	96Cr	1.06TCr	889.75Cr	374.9Cr	976.99Cr
Unlevered Free Cash Flow	165.95Cr	1.13TCr	977.25Cr	468.65Cr	1.06TCr
Change In Net Working Capital	547.5Cr	-409.6Cr	-240.7Cr	304.8Cr	-237.9Cr
Net Debt Issued / Repaid	66Cr	-255.9Cr	-28Cr	106Cr	-67Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.29	3.55	3.79	3.93	4.09
Return on Total Capital	6.16	6.71	7.29	8.05	8.75
Return On Equity %	11.1	14.64	11.79	8.63	15.13
Return on Common Equity	11.01	14.5	11.36	7.87	14.4
Margin Analysis
Gross Profit Margin %	13.19	13	12.89	10.51	9.3
SG&A Margin	7.36	7.27	7.36	5.9	4.93
EBITDA Margin %	5.72	5.73	5.53	4.63	4.38
EBITA Margin %	5.57	5.59	5.4	4.53	4.3
EBIT Margin %	4.69	4.7	4.6	3.92	3.73
Income From Continuing Operations Margin %	3.11	3.74	2.75	1.53	2.29
Net Income Margin %	3.08	3.69	2.64	1.39	2.17
Net Avail. For Common Margin %	3.08	3.69	2.64	1.39	2.17
Normalized Net Income Margin	2.5	2.49	2.32	1.95	1.89
Levered Free Cash Flow Margin	0.55	5.86	4.56	1.52	3.55
Unlevered Free Cash Flow Margin	0.95	6.26	5	1.9	3.87
Asset Turnover
Asset Turnover	1.12	1.21	1.32	1.6	1.75
Fixed Assets Turnover	102.16	121.76	153.27	289.88	322.46
Receivables Turnover (Average Receivables)	12.97	11.36	11.19	11.86	10.41
Inventory Turnover (Average Inventory)	43.88	36.95	32.64	35.85	35.54
Short Term Liquidity
Current Ratio	0.83	0.73	0.77	0.84	0.85
Quick Ratio	0.49	0.59	0.55	0.56	0.67
Operating Cash Flow to Current Liabilities	0.17	0.21	0.24	0.18	0.17
Days Sales Outstanding (Average Receivables)	28.15	32.14	32.62	30.86	35.05
Days Outstanding Inventory (Average Inventory)	8.32	9.88	11.18	10.21	10.27
Average Days Payable Outstanding	49.08	54.03	56.81	54.46	57.49
Cash Conversion Cycle (Average Days)	-12.61	-12.02	-13	-13.39	-12.17
Long Term Solvency
Total Debt/Equity	72.62	70.19	67.69	77.52	75.14
Total Debt / Total Capital	42.07	41.24	40.37	43.67	42.9
LT Debt/Equity	66.89	63.28	61.48	70.16	73.72
Long-Term Debt / Total Capital	38.75	37.18	36.66	39.52	42.09
Total Liabilities / Total Assets	69.54	68.77	69.66	73.54	73.48
EBIT / Interest Expense	7.29	7.29	6.42	6.46	7.33
EBITDA / Interest Expense	9.08	9.03	7.82	7.63	8.6
(EBITDA - Capex) / Interest Expense	8.05	7.91	6.7	6.69	7.74
Total Debt / EBITDA	3.37	3.01	2.86	2.79	2.61
Net Debt / EBITDA	2.78	2.35	2.07	2.08	1.89
Total Debt / (EBITDA - Capex)	3.8	3.43	3.34	3.18	2.9
Net Debt / (EBITDA - Capex)	3.14	2.69	2.41	2.37	2.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.53	3.7	8.17	26.56	11.24
Gross Profit, 1 Yr. Growth %	-5.14	2.23	7.14	3.13	-1.56
EBITDA, 1 Yr. Growth %	-3.96	3.8	4.14	5.53	5.25
EBITA, 1 Yr. Growth %	-3.84	3.92	4.15	5.78	5.45
EBIT, 1 Yr. Growth %	-4.78	3.95	5.57	7.28	5.85
Earnings From Cont. Operations, 1 Yr. Growth %	-36.21	24.58	-20.79	-29.67	66.44
Net Income, 1 Yr. Growth %	-36.57	24.29	-22.97	-33.5	73.47
Normalized Net Income, 1 Yr. Growth %	-2.66	3.35	0.4	6.22	7.98
Diluted EPS Before Extra, 1 Yr. Growth %	-31.49	35.41	-18.78	-30.3	83
Accounts Receivable, 1 Yr. Growth %	21.8	16.11	4.43	37.91	18.55
Inventory, 1 Yr. Growth %	17.6	28.34	18.17	18.55	9.65
Net Property, Plant and Equip., 1 Yr. Growth %	-4.59	-21.82	-4.15	-5.59	5.92
Total Assets, 1 Yr. Growth %	-0.36	-7.07	6.17	2.04	1.31
Tangible Book Value, 1 Yr. Growth %	8.57	1.88	-12.84	12.18	-2.91
Common Equity, 1 Yr. Growth %	-6.38	-4.75	3.46	-11.23	1.66
Cash From Operations, 1 Yr. Growth %	-30.52	20.37	36.47	-12.27	-7.35
Capital Expenditures, 1 Yr. Growth %	5.48	12.22	21.47	-10.62	-13.8
Levered Free Cash Flow, 1 Yr. Growth %	-92.34	1T	-15.99	-58.49	160.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-87.61	580.97	-13.65	-52.69	127.14
Dividend Per Share, 1 Yr. Growth %	9.9T	12	9.82	13.82	7.86
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.47	6.09	5.91	17	18.65
Gross Profit, 2 Yr. CAGR %	-4.31	-1.52	4.74	5.11	0.76
EBITDA, 2 Yr. CAGR %	-7.28	-0.16	4.12	4.73	5.39
EBITA, 2 Yr. CAGR %	-7.32	-0.04	4.19	4.86	5.61
EBIT, 2 Yr. CAGR %	-3.81	-0.51	4.94	6.29	6.56
Earnings From Cont. Operations, 2 Yr. CAGR %	2.84	-10.86	-0.44	-25.36	8.19
Net Income, 2 Yr. CAGR %	2.52	-11.21	-1.94	-28.43	7.4
Normalized Net Income, 2 Yr. CAGR %	-1.56	0.3	2.08	3.27	7.1
Diluted EPS Before Extra, 2 Yr. CAGR %	8.18	-3.68	5.08	-24.76	12.94
Accounts Receivable, 2 Yr. CAGR %	18.65	18.92	10.12	19.08	27.86
Inventory, 2 Yr. CAGR %	18.27	22.85	23.15	18.36	14.01
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.54	-13.63	-13.43	-20.22	0
Total Assets, 2 Yr. CAGR %	-0.28	-3.78	-0.69	4.09	1.67
Tangible Book Value, 2 Yr. CAGR %	-4.89	5.62	-5.51	-1.24	4.36
Common Equity, 2 Yr. CAGR %	1.94	-5.57	-0.95	-4.16	-5
Cash From Operations, 2 Yr. CAGR %	-12.93	-8.55	28.17	9.42	-9.85
Capital Expenditures, 2 Yr. CAGR %	4.84	8.8	16.75	4.2	-12.22
Levered Free Cash Flow, 2 Yr. CAGR %	-44.9	-8.16	203.83	-40.38	4.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	-36.9	-8.14	142.4	-35.76	3.66
Dividend Per Share, 2 Yr. CAGR %	900	958.3	10.91	11.8	10.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	52.95	5.54	6.78	12.39	15.05
Gross Profit, 3 Yr. CAGR %	12.04	-2.18	1.32	4.2	2.84
EBITDA, 3 Yr. CAGR %	24.02	-3.73	1.37	4.73	4.9
EBITA, 3 Yr. CAGR %	24.13	-3.72	1.46	4.87	5.05
EBIT, 3 Yr. CAGR %	18.8	-1.29	1.62	5.89	6.14
Earnings From Cont. Operations, 3 Yr. CAGR %	26.96	9.63	-14.15	-11.33	-2.49
Net Income, 3 Yr. CAGR %	26.71	9.32	-15.17	-13.85	-3.86
Normalized Net Income, 3 Yr. CAGR %	14.39	0.05	0.5	3.44	4.82
Diluted EPS Before Extra, 3 Yr. CAGR %	14.28	16.59	-8.85	-8.36	1.18
Accounts Receivable, 3 Yr. CAGR %	12.75	17.8	13.88	18.09	18.91
Inventory, 3 Yr. CAGR %	9.68	21.54	21.27	21.6	15.38
Net Property, Plant and Equip., 3 Yr. CAGR %	9.05	-9.44	-10.58	-20.76	-12.32
Total Assets, 3 Yr. CAGR %	0.36	-2.6	-0.58	0.21	3.15
Tangible Book Value, 3 Yr. CAGR %	-8.28	-2.4	-0.75	-0.03	-1.8
Common Equity, 3 Yr. CAGR %	4.72	-0.34	-2.79	-4.5	-2.26
Cash From Operations, 3 Yr. CAGR %	24.02	-3	4.51	12.95	3.51
Capital Expenditures, 3 Yr. CAGR %	29.77	7.24	12.87	6.81	-2.18
Levered Free Cash Flow, 3 Yr. CAGR %	-55.78	49.54	-10.8	57.26	-2.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	-47.13	39.44	-9.97	41.24	-2.14
Dividend Per Share, 3 Yr. CAGR %	364.16	382.03	397.32	11.87	10.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	34.3	33.98	32.04	9.98	11.38
Gross Profit, 5 Yr. CAGR %	12	10.75	9.05	0.7	1.09
EBITDA, 5 Yr. CAGR %	22.98	18.75	15.65	-0.24	3.05
EBITA, 5 Yr. CAGR %	23.48	19.02	15.74	-0.18	3.19
EBIT, 5 Yr. CAGR %	20.19	15.49	13.07	1.92	3.68
Earnings From Cont. Operations, 5 Yr. CAGR %	24.06	24.76	15.22	-5.9	-5.83
Net Income, 5 Yr. CAGR %	23.51	24.41	14.39	-7.62	-6.77
Normalized Net Income, 5 Yr. CAGR %	18.22	12.71	9.32	1.43	3.09
Diluted EPS Before Extra, 5 Yr. CAGR %	16.95	19.42	10.53	-2.05	-0.69
Accounts Receivable, 5 Yr. CAGR %	37.03	42.34	11.69	18.31	18.91
Inventory, 5 Yr. CAGR %	-	83.76	14.88	20.25	18.32
Net Property, Plant and Equip., 5 Yr. CAGR %	16.75	11.47	-0.57	-13.92	-12.85
Total Assets, 5 Yr. CAGR %	21.14	18.44	-0.06	0.01	0.32
Tangible Book Value, 5 Yr. CAGR %	40.06	41.5	-7.02	-1.83	1.22
Common Equity, 5 Yr. CAGR %	27.98	26.76	2.41	-1.98	-3.68
Cash From Operations, 5 Yr. CAGR %	12.3	16.2	25.66	1.79	-1.49
Capital Expenditures, 5 Yr. CAGR %	20.14	22.42	24.4	6.01	2.07
Levered Free Cash Flow, 5 Yr. CAGR %	-31.38	-0.56	-4.34	3.46	-4.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	-23.86	0.56	-2.74	2.37	-4.49
Dividend Per Share, 5 Yr. CAGR %	151.19	156.95	161.81	168.67	172.77